Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics, Inc.（ALDX）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
aldx · 股价预测 · 19 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 19 位华尔街分析师
Buy
19 位分析师
共识
评级分布
12 个月目标价
High
$12.00
Consensus
$9.67
+455.7% upside
Low
$7.00
Median: $10 · Last Close: $1.74
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$9.67
455.7% upside
High Target
$12
589.7%
Low Target
$7
302.3%
Current Price
$1.74
as of today
Based on analyst price targets, the ALDX stock price prediction for the next 12 months ranges from $7 to $12. The consensus ALDX price forecast of $9.67 implies 455.7% upside from the current price of $1.74.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $1.77 | ↑ 1.80% |
1-day model range: $1.76–$1.79. Peak: $1.79 (+1.80%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ALDX · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-18 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2025-11-10 | BTIG | Maintains | Buy→Buy |
| 2025-05-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-04-07 | BTIG | Maintains | Buy→Buy |
| 2025-04-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-03 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-08-09 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-08-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-05-06 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-05-06 | Oppenheimer | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Aldeyra Therapeutics, Inc. (ALDX) stock. Of the recent 51 rating actions, 1 were upgrades and 2 were downgrades. 19 analysts currently cover ALDX.
分析师推荐趋势
ALDX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$22M
↓ 90.5% YoY
Revenue Next Year
$11M
↓ 48.4% YoY
EPS This Year
$-0.41
EPS Next Year
$-0.21
↓ 49.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast ALDX EPS of $-0.41 for the current fiscal year, based on estimates from 2 analysts. The ALDX revenue forecast is $22M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
ALDX 股价预测由两类独立数据源支撑：来自 19 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。ALDX 的共识目标价为 $9.67（+455.7% 上行空间），分析师共识为 Buy。
ALDX 的短期预测（明日）为 $1.77（+1.80%）。
Aldeyra Therapeutics, Inc. 在 NASDAQ 上市，代码 ALDX。ALDX 在 2027 年的整体展望偏积极，在覆盖分析师中约 95% 对应 Buy 共识。
常见问题
ALDX 预测 · 8 个问题根据 19 位华尔街分析师，ALDX 的 12 个月平均目标价为 $9.67，最高 $12.00、最低 $7.00。若有图表，中位目标价可在上方查看。相对当前价 $1.74，隐含约 +455.7% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.